Exclusive

Publication

Byline

General Atlantic-backed ASG Eye Hospital eyes Rs.2,000 crore investment for expansion by 2030

New Delhi, Dec. 4 -- General Atlantic and Kedaara Capital-backed eyecare chain ASG Eye Hospital plans to invest Rs.1,500-2,000 crore by 2030 to expand its footprint in small cities, signalling growing... Read More


APIs to innovation: Bulk drug cos ramp up CDMO bets

MUMBAI, Dec. 1 -- Once focused on low-margin active pharmaceutical ingredients (APIs), India's bulk drug manufacturers are raising their ambitions, with several now investing heavily in R&D to win con... Read More


From APIs to innovation: India's bulk drug makers ramp up CDMO bets

MUMBAI, Nov. 29 -- Once focused on low-margin active pharmaceutical ingredients (APIs), India's bulk drug manufacturers are stepping up their ambitions. Several are now pouring capital into research a... Read More


Mint Explainer: Delhi air pollution crisis: Does India have a health adaptation plan?

Mumbai, Nov. 20 -- India's national capital has seen two citizen-led protests in November over the government's inaction to address dangerously worsening air quality. Health experts have declared the... Read More


Qure.ai to scale up govt partnerships for health screenings in India

New Delhi, Nov. 18 -- Healthcare startup Qure.ai is betting on partnerships with central and state governments as it seeks to scale its artificial intelligence-led diagnostic tools, particularly for d... Read More


OneSource optimistic on weight-loss drug prospects, raises FY28 revenue guidance to over $500 mn

New Delhi, Nov. 13 -- Backed by strong demand across its drug-device and biologics businesses, OneSource Speciality Pharma has raised its FY28 revenue guidance from $400 million to over $500 million, ... Read More


Biocon banks on weight-loss drugs, raises stake in biosimilar arm

Mumbai, Nov. 12 -- Weight-loss and diabetes drugs such as semaglutide and liraglutide are expected to drive near-term growth in Biocon Ltd's generics business, chief executive and managing director Si... Read More


Novo Nordisk slashes weight-loss drug Wegovy's prices as competition heats up

New Delhi, Nov. 11 -- Danish drugmaker Novo Nordisk on Tuesday announced it was slashing the price of its weight-loss drug Wegovy in India. The company said the monthly price of its once-a-week inject... Read More


Mint Explainer | Why the drug regulator is cracking down on small and medium-sized pharma companies

New Delhi, Nov. 11 -- India's top drug regulator has ordered a nationwide crackdown on pharmaceutical manufacturers to enforce stricter quality standards. India's Drugs Controller General of India (DC... Read More


Novo Nordisk bets on Emcure to win India's weight-loss drug war

New Delhi, Nov. 10 -- Danish drugmaker Novo Nordisk on Monday announced an exclusive partnership with Pune-based Emcure Pharmaceuticals to widely distribute its weight-loss therapy semaglutide, as com... Read More